Since then, Boustead won a contract worth RM300 million to build a four-storey data centre and adjacent facilities. It also won a contract for an integrated pharmaceutical manufacturing and research and development (R&D) facility at Tuas.
Ada Lim of OCBC Investment Research has kept her "buy" call and $1.39 fair value on Boustead Singapore (SGX:F9D
) after the engineering company replenished its order book to $428 million.
Lim says that when the company reported its 1HFY2025 earnings, its engineering order book had dipped to as low as $157 million as of Sept 2024.
